Outcome of pregnancy in women with hereditary thrombophilia

International Journal of Gynecology and Obstetrics

Volumn 74, Issue 3, 2001, Pages 247-253

  Ogueh, O ^a   Chen, M F ^a   Spurll, G ^a   Benjamin, A ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Heparin; Hereditary thrombophilia; Pregnancy outcome

Indexed keywords

HEPARIN;

ADULT; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS WASTAGE; GENETIC DISORDER; HUMAN; MEDICAL RECORD; PERINATAL MORTALITY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SPONTANEOUS ABORTION; THROMBOPHILIA; THROMBOSIS;

EID: 0034866260     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(01)00447-7     Document Type: Article

References (29)

1. Mutation in blood coagulation factor V associated with resistance to activated protein C
2. The challenge of thrombophilia in maternal-fetal medicine
3. Second-trimester pregnancy loss is associated with activated C resistance
4. Obstetric complications of antiphospholipid antibodies
5. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta
6. Thrombosis in pregnancy: maternal and fetal issues
7. Thrombophilias and adverse outcomes of pregnancy - what should a clinician do?
8. Increased frequency of genetic thrombophilia in women with complications of pregnancy
9. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies
10. Ultrasound evaluation of amniotic fluid volume. I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome
11. Risk factors for pregnancy associated venous thromboembolism
12. Factor V Leiden, prothrombin 20210G→A and the MTHFR C677T mutations in childhood stroke
13. Management of patients with hereditary defects predisposing to thrombosis including pregnant women
14. Increased fetal loss in women with heritable thrombophilia
15. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses
16. First-trimester repeated abortion is not associated with activated protein C resistance
17. The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation, BJOG
18. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies
19. Resistance to activated protein C and the Leiden mutation: high prevalence in patients with abruptio placentae
20. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of pre-eclampsia or fetal growth restriction: a preliminary study
21. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent - the Nimes Obstetricians and Haematologists Study5 (NOHA5)
22. Activated protein C resistance (FV:Q506) and pregnancy
23. Placental thrombosis and second trimester miscarriage in association with activated protein C resistance
24. Small for gestational age infant in association with maternal prothrombin gene variant (nt 20210A)
25. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?
26. Severe pre-eclampsia associated with coinheritance of factor V Leiden mutation and protein S deficiency
27. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism
28. The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome
29. Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome